Gilead Sciences, Inc. and Genesis Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies across ...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that the Company accepted offers from multiple leading biotech institutional and individual investors to purchase an ...

Ins("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in-class small molecule ...

According to Rakovina Therapeutics Executive Chairman Jeffrey Bacha, “This collaboration is an ideal addition to our already established Deep Docking AI partnership as it expands Rakovina Therapeutics ...

Gilead Sciences (GILD) and Genesis Therapeutics have entered into a strategic collaboration to discover and develop small molecule ...

New AI model creates virtual colorations of cancer tissue for enhanced diagnostics Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic ...

OpenAI is in need of a new typeface, but a recent reveal of a new logo left some employees mystified, Fortune has learned.

In this article, you will learn about all the applications of plasma in manufacturing, especially in industries that call for ...

A new study published in the journal Physical Review Letters, conducted by an international team of researchers from the ...

In their quest for a more power-efficient future, researchers at Tohoku University have effectively boosted the capacity, ...

Researchers have engineered innovative molecules poised to transform computing by mimicking the human brain’s processing ...

Researchers at Tokyo Metropolitan University have made significant progress in developing an industrial process to convert ...